Mr. Thomas Crew Morrison, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 160 Dogwood Lane, Moutain Home, TN 37684 Phone: 423-926-1171 Fax: 423-979-3685 |
News Archive
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.
MarketWatch: After health negotiations stretched until the wee hours of the morning Friday, "House Majority Leader Steny Hoyer, D-Md., said [later that morning] ... congressional Democrats are 'very close' to reaching final agreement on legislation." He said he hoped that "within the next 24, 48, 72 hours" such agreement would be reached. Meanwhile, Democratic leaders are expected to return to the White House today for more negotiations. This would "mark the third straight day of talks between Obama and Democrats over the health bill. Obama is anxious to sign a bill and move on to other issues including job creation" (Schroeder, 1/15).
Researchers have developed a risk assessment scoring system that they believe may better identify certain adults- especially African Americans- at high risk of developing type 2 diabetes, heart disease and stroke than does the current system of diagnosing the metabolic syndrome.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
The Renfrew Center, the country's leading authority on eating disorder treatment and research, recently announced the expansion of its services into Central America through a partnership with the Guatemala-based AKASA treatment center. The first center in Central America exclusively dedicated to the treatment of women with eating disorders, AKASA now operates as an independent affiliate of The Renfrew Center.
› Verified 2 days ago